Credit: Investing.com -
Investing.com - Health care conglomerate Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter earnings on the back of strong revenue figures, it announced early Tuesday.
J&J said earnings per share came in at $1.66 in the second quarter, beating expectations for earnings of $1.55 per share. The company's second quarter revenue totaled $19.5 billion, above expectations for revenue of $18.98 billion.
Domestic sales increased 14.9% in the second quarter, while international sales increased 4.4%, reflecting operational growth of 5% and a negative currency impact of 0.6%.
The firm now sees full year adjusted earnings per share in a range between $5.85 and $5.92, compared to expectations for adjusted earnings of $5.90 per share.
"Our strong second-quarter results reflect the continued success of our new product launches and the progress we have made in achieving our near-term priorities," said Alex Gorsky, Chairman and Chief Executive Officer.
Immediately after the earnings announcement, J&J (NYSE:JNJ)shares rose 0.6% in trading prior to the opening bell.
Meanwhile, the outlook for U.S. equity markets was modestly higher. The Dow futures indicated a gain of 0.15%, the S&P 500 pointed to a rise of 0.1%, while the Nasdaq 100 indicated an increase of 0.1%.
Investing.com offers an extensive set of professional tools for the financial markets.
Read more News on Investing.com and download the new Investing.com Stocks & Forex App for Android!
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
